Moderated By: Sarah Kliff, Senior Editor, Vox @sarahkliff
Alan Coukell, Senior Director, Drugs and Medical Devices, Pew Charitable Trusts @coukell
Sharon Levine, Associate Executive Medical Director, The Permanente Group @KPShare
Sarah Radcliffe, Executive Vice President for Health, Biotechnology Industry Organization @IAmBiotech
Allan Coukell is senior director of drugs and medical devices, overseeing Pew’s initiatives related to drug and medical device innovation and safety, medical conflicts of interest, the pharmaceutical supply chain, pharmacy compounding, antibiotics, prescription drug abuse, the Food and Drug Administration, and specialty drugs, and other efforts related to health costs and care delivery.
Sarah Kliff is Senior Editor for Vox.
Sharon Levine, MD, is a nationally respected expert and frequent speaker on issues of health policy, drug use management, and the design and delivery of health care services. As associate executive medical director for The Permanente Medical Group of Northern California since 1991—the largest medical group in the country—she has responsibility for the recruitment, compensation, clinical education, management training, and leadership development for the group’s physicians; government and community relations; health policy and external affairs; and pharmacy policy and drug use management.
Sara Radcliffe is the Executive Vice President for Health at the Biotechnology Industry Organization (BIO). In that role, Ms. Radcliffe has responsibility for identifying, developing and implementing strategic BIO approaches to improving the ability of BIO's human healthcare focused companies to research and develop life-saving and life-enhancing biotechnology products, and to bring these products to market. Among the priorities of BIOs Health are: promoting a science-based FDA regulatory environment, enhancing patient access to innovative therapies and vaccines through reimbursement systems that recognize the value of biotechnology products, ensuring that biosimilars policies protect patient safety and promote innovation, and securing support for policies that advance personalized medicine and emergency preparedness. Prior to joining BIO, Ms. Radcliffe served as Senior Director, Biologics & Biotechnology at the Pharmaceutical Research and Manufacturers of America (PhRMA). She also served in the Alliance and Technology Group at SmithKline Beecham Pharmaceuticals as a Research and Development Policy Analyst, working on evaluation and communication of the promise, ethics, and impact of rapidly-developing technologies in DNA Research. In addition she worked for the Core Services Committee of the New Zealand Ministry of Health. Ms. Radcliffe holds a Master of Public Health and a Master of Arts in Philosophy from the Johns Hopkins University.